400 related articles for article (PubMed ID: 32349587)
1. Comparison of Cell and Organoid-Level Analysis of Patient-Derived 3D Organoids to Evaluate Tumor Cell Growth Dynamics and Drug Response.
Kim S; Choung S; Sun RX; Ung N; Hashemi N; Fong EJ; Lau R; Spiller E; Gasho J; Foo J; Mumenthaler SM
SLAS Discov; 2020 Aug; 25(7):744-754. PubMed ID: 32349587
[TBL] [Abstract][Full Text] [Related]
2. Anti-cancer activity of amorphous curcumin preparation in patient-derived colorectal cancer organoids.
Elbadawy M; Hayashi K; Ayame H; Ishihara Y; Abugomaa A; Shibutani M; Hayashi SM; Hazama S; Takenouchi H; Nakajima M; Tsunedomi R; Suzuki N; Nagano H; Shinohara Y; Kaneda M; Yamawaki H; Usui T; Sasaki K
Biomed Pharmacother; 2021 Oct; 142():112043. PubMed ID: 34411919
[TBL] [Abstract][Full Text] [Related]
3. Plocabulin Displays Strong Cytotoxic Activity in a Personalized Colon Cancer Patient-Derived 3D Organoid Assay.
Costales-Carrera A; Fernández-Barral A; Bustamante-Madrid P; Guerra L; Cantero R; Barbáchano A; Muñoz A
Mar Drugs; 2019 Nov; 17(11):. PubMed ID: 31752287
[TBL] [Abstract][Full Text] [Related]
4. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
Xie BY; Wu AW
Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
[TBL] [Abstract][Full Text] [Related]
5. Tumour organoids and assembloids: Patient-derived cancer avatars for immunotherapy.
Mei J; Liu X; Tian HX; Chen Y; Cao Y; Zeng J; Liu YC; Chen Y; Gao Y; Yin JY; Wang PY
Clin Transl Med; 2024 Apr; 14(4):e1656. PubMed ID: 38664597
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis.
Le Compte M; Cardenas De La Hoz E; Peeters S; Smits E; Lardon F; Roeyen G; Vanlanduit S; Prenen H; Peeters M; Lin A; Deben C
J Vis Exp; 2022 Dec; (190):. PubMed ID: 36622028
[TBL] [Abstract][Full Text] [Related]
7. Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study.
Votanopoulos KI; Mazzocchi A; Sivakumar H; Forsythe S; Aleman J; Levine EA; Skardal A
Ann Surg Oncol; 2019 Jan; 26(1):139-147. PubMed ID: 30414038
[TBL] [Abstract][Full Text] [Related]
8. Light and electron microscopy continuum-resolution imaging of 3D cell cultures.
D'Imprima E; Garcia Montero M; Gawrzak S; Ronchi P; Zagoriy I; Schwab Y; Jechlinger M; Mahamid J
Dev Cell; 2023 Apr; 58(7):616-632.e6. PubMed ID: 36990090
[TBL] [Abstract][Full Text] [Related]
9. Functional Optical Imaging of Primary Human Tumor Organoids: Development of a Personalized Drug Screen.
Walsh AJ; Cook RS; Skala MC
J Nucl Med; 2017 Sep; 58(9):1367-1372. PubMed ID: 28588148
[TBL] [Abstract][Full Text] [Related]
10. Prospective derivation of a living organoid biobank of colorectal cancer patients.
van de Wetering M; Francies HE; Francis JM; Bounova G; Iorio F; Pronk A; van Houdt W; van Gorp J; Taylor-Weiner A; Kester L; McLaren-Douglas A; Blokker J; Jaksani S; Bartfeld S; Volckman R; van Sluis P; Li VS; Seepo S; Sekhar Pedamallu C; Cibulskis K; Carter SL; McKenna A; Lawrence MS; Lichtenstein L; Stewart C; Koster J; Versteeg R; van Oudenaarden A; Saez-Rodriguez J; Vries RG; Getz G; Wessels L; Stratton MR; McDermott U; Meyerson M; Garnett MJ; Clevers H
Cell; 2015 May; 161(4):933-45. PubMed ID: 25957691
[TBL] [Abstract][Full Text] [Related]
11. A fully automated high-throughput workflow for 3D-based chemical screening in human midbrain organoids.
Renner H; Grabos M; Becker KJ; Kagermeier TE; Wu J; Otto M; Peischard S; Zeuschner D; TsyTsyura Y; Disse P; Klingauf J; Leidel SA; Seebohm G; Schöler HR; Bruder JM
Elife; 2020 Nov; 9():. PubMed ID: 33138918
[TBL] [Abstract][Full Text] [Related]
12. OrBITS: label-free and time-lapse monitoring of patient derived organoids for advanced drug screening.
Deben C; De La Hoz EC; Compte ML; Van Schil P; Hendriks JMH; Lauwers P; Yogeswaran SK; Lardon F; Pauwels P; Van Laere S; Bogaerts A; Smits E; Vanlanduit S; Lin A
Cell Oncol (Dordr); 2023 Apr; 46(2):299-314. PubMed ID: 36508089
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic heterogeneity of 2D organoid reflects clinical tumor characteristics.
Fujino S; Ito A; Ohue M; Yasui M; Mizushima T; Doki Y; Mori M; Miyoshi N
Biochem Biophys Res Commun; 2019 May; 513(2):332-339. PubMed ID: 30955861
[TBL] [Abstract][Full Text] [Related]
14. Establishment of 2.5D organoid culture model using 3D bladder cancer organoid culture.
Abugomaa A; Elbadawy M; Yamanaka M; Goto Y; Hayashi K; Mori T; Uchide T; Azakami D; Fukushima R; Yoshida T; Shibutani M; Yamashita R; Kobayashi M; Yamawaki H; Shinohara Y; Kaneda M; Usui T; Sasaki K
Sci Rep; 2020 Jun; 10(1):9393. PubMed ID: 32523078
[TBL] [Abstract][Full Text] [Related]
15. High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids.
Choo N; Ramm S; Luu J; Winter JM; Selth LA; Dwyer AR; Frydenberg M; Grummet J; Sandhu S; Hickey TE; Tilley WD; Taylor RA; Risbridger GP; Lawrence MG; Simpson KJ
SLAS Discov; 2021 Oct; 26(9):1107-1124. PubMed ID: 34111999
[TBL] [Abstract][Full Text] [Related]
16. Screening drug effects in patient-derived cancer cells links organoid responses to genome alterations.
Jabs J; Zickgraf FM; Park J; Wagner S; Jiang X; Jechow K; Kleinheinz K; Toprak UH; Schneider MA; Meister M; Spaich S; Sütterlin M; Schlesner M; Trumpp A; Sprick M; Eils R; Conrad C
Mol Syst Biol; 2017 Nov; 13(11):955. PubMed ID: 29180611
[TBL] [Abstract][Full Text] [Related]
17. Patient-Derived Organoid Model in the Prediction of Chemotherapeutic Drug Response in Colorectal Cancer.
Hao M; Cao Z; Wang Z; Xin J; Kong B; Xu J; Zhang L; Chen P
ACS Biomater Sci Eng; 2022 Aug; 8(8):3515-3525. PubMed ID: 35696669
[TBL] [Abstract][Full Text] [Related]
18. Patient-Derived Cancer Organoid Cultures to Predict Sensitivity to Chemotherapy and Radiation.
Pasch CA; Favreau PF; Yueh AE; Babiarz CP; Gillette AA; Sharick JT; Karim MR; Nickel KP; DeZeeuw AK; Sprackling CM; Emmerich PB; DeStefanis RA; Pitera RT; Payne SN; Korkos DP; Clipson L; Walsh CM; Miller D; Carchman EH; Burkard ME; Lemmon KK; Matkowskyj KA; Newton MA; Ong IM; Bassetti MF; Kimple RJ; Skala MC; Deming DA
Clin Cancer Res; 2019 Sep; 25(17):5376-5387. PubMed ID: 31175091
[TBL] [Abstract][Full Text] [Related]
19. 3D imaging of colorectal cancer organoids identifies responses to Tankyrase inhibitors.
Badder LM; Hollins AJ; Herpers B; Yan K; Ewan KB; Thomas M; Shone JR; Badder DA; Naven M; Ashelford KE; Hargest R; Clarke AR; Esdar C; Buchstaller HP; Treherne JM; Boj S; Ramezanpour B; Wienke D; Price LS; Shaw PH; Dale TC
PLoS One; 2020; 15(8):e0235319. PubMed ID: 32810173
[TBL] [Abstract][Full Text] [Related]
20. Viability Analysis and High-Content Live-Cell Imaging for Drug Testing in Prostate Cancer Xenograft-Derived Organoids.
Van Hemelryk A; Erkens-Schulze S; Lim L; de Ridder CMA; Stuurman DC; Jenster GW; van Royen ME; van Weerden WM
Cells; 2023 May; 12(10):. PubMed ID: 37408211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
